STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
Will New Business Development VP Hire and Lens Expansion Strategy Change STAAR Surgical's (STAA) Narrative
Has STAAR Surgical (STAA) Fallen Far Enough To Look Cheap?
STAAR Surgical (STAA) Is Getting Attention Again, But What Is Behind It?
3 Reasons STAA is Risky and 1 Stock to Buy Instead
STAAR Surgical Names Andrew Pilon as Vice President of Business Development
Winners And Losers Of Q2: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
STAAR Surgical: A Recovery Story Priced As Growth
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know
STAAR Surgical jumps on Stifel upgrade citing China growth potential
STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside
Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $31
STAAR Surgical stock ticks higher on $50M buyback authorization
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
China-Led Rebound and New Leadership Might Change The Case For Investing In STAAR Surgical (STAA)
STAAR Surgical (STAA) Swings To Profit, Is A 22% Undervalued View Justified?
STAAR Surgical (STAA) Swings To Profit On China Rebound
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.